Al SarrafM., AmerM. H., VaitkeviciusV. K.: Chemotherapy and survival in patients with urinary bladder cancer. Proc. Amer. Ass. Cancer Res., 18; 116 (1977).
2.
BanksM. D., PontesJ. E., IzbickiR. H., PierceJ. M.: Topical instillation of doxorubicin hydrochloride in the treatment of recurring superficial transitional cell carcinoma of the bladder. J. Urol., 118; 757 (1977).
3.
BlumR. H., CarterS. K.: Adryamicin: A new anticancer drug with significant clinical activity. Ann. Intern. Med., 80; 249–259 (1974).
4.
HendersonI. C., FreiE.: Adriamicina e cuore. N. Engl. J. Med., 300; 310 (1979).
5.
JonesH. C.jr., SwinneyJ.: Thiotepa in the treatment of tumours of the bladder. Lancet, 2; 615 (1961).
6.
Martinez-PineiroJ. A., ArocenaLanz F., HernandezArmero A., CamachoM.: Tratamiento y profilaxis de los tumores vecicales con tio-tepa. XVI Congr. Soc. Intern. Urol. (Doin, Paris), 2; 511 (1973).
7.
MerrinC., CartagenaR., WajsmanZ., BaumgartnerG. P.: Chemotherapy of bladder carcinoma with cyclophosphamide and adriamycin. J. Urol., 114; 884–887 (1975).
8.
MerrinC., BeckleyS.: Adjuvant chemotherapy for bladder cancer with doxorubicin hydrochloride and cyclophosphamide: preliminary report. J. Urol., 119; 62 (1978).
9.
MillsB. A., RobertsR. W.: Cyclophosphamide-induced cardiomyopathy: a report of two cases and review of the English literature. Cancer, 43; 2223–2226 (1979).
10.
O'ConnellT. X., BerenbaumM. C.: Cardiac and pulmunary effects of high doses of Cyclophosphamide and Isophosphamide. Cancer Res., 34; 1586–1591 (1974).
11.
Pavone-MacalusoM.: Local chemotherapy of papillary neoplasias of the bladder. Panminerva med., 13; 240 (1971).
12.
PragaC.: Adriamycin cardiotoxicity: a survey af 1273 patients. Cancer Treat. Reports, 63; n. 5 (1979).
13.
RosowskyA.: Cyclophosphamide and related mustards. In « Advances in cancer chemotherapy », 1; 179–191 (1979).
14.
TronerM., HemstreetG.: Cyclophosphamide, adriamycin and cis-platinum (CAP) chemotherapy of metastatic transitional cell carcinoma of the bladder. Proc. Amer. Ass. Cancer Res., 19; 161 (1978).
15.
WhitmoreW. F.jr., PhillipsR. F., GrabstaldH., BronsteinE. L., MackenzieA. R., HutsuO.: Experience with preoperative irradiation followed by radical cistectomy for treatment of bladder cancer. Amer. J. Roentgenol. Radium Ther. Nucl. Med., 90; 1016–1022 (1963).
16.
WhitmoreW. F.jr.. BatataM. A., GhoneimM. A., GrabstaldH., UnalA.: Radical cystectomy with or without prior irradiation in the treatment of bladder cancer. J. Urol., 118; 184–187 (1977).
17.
WhitmoreW. F.jr., BatataM. A., HilarisB. S., ReddyG. N., UnalA., GhoneimM. A., GrabstaldH., ChuF.: A comparative study of two preoperative radiation regimens with cystectomy for bladder cancer. Cancer, 40; 1077–1086 (1977).
18.
WilliamsS. D., RobinR. J., DonohueJ. P., EinhorrL. H.: Chemotherapy of bladder cancer with cis-diamminodichloroplatinum (CAP) adriamycin (ADR), and 5-Fluorouracil (5-Fu). Amer. Ass. Cancer Res., 19; 37 (1978).
19.
YagodaA., WatsonR. C., GrabstaldH., BarzellW. E., WhitmoreW. F.jr.: Adriamycin and cyclophosphamide in advanced bladder cancer. Cancer Treat. Reports, 61; 97–99 (1977).
